| Date |
Publication |
Title |
| Nov 13, 2024 |
Precision Medicine Online |
Cancer Study Sees Tailored Treatment, Outcome Boost with Comprehensive Genomic Profiling |
| Nov 12, 2024 |
ASCO Daily News |
Comprehensive Genomic Profiling Improves Precision Therapy Use and Patient Survival |
| Nov 11, 2024 |
GenomeWeb |
Illumina Provides Updates on Multiomics Product Pipeline at ASHG |
| Nov 8, 2024 |
Pharmaphorum |
NHS Wales partners with Illumina on genomics drive |
| Nov 7, 2024 |
CGTN |
Global medical firms showcase cutting-edge products at CIIE |
| Nov 3, 2024 |
GEN Magazine |
At ASHG, Illumina to Share Updates to Sequencing, Proteomics, and Single-Cell Technologies |
| Nov 1, 2024 |
GEN Magazine |
NGS Sample Preparation Taking the Pain Out of Painstaking |
| Nov 1, 2024 |
GEN Magazine |
Omics Data Analysis: A Range of Options |
| Nov 1, 2024 |
The Guardian - Nigeria |
Championing personalized cancer care through NGS enabled precision |
| Oct 28, 2024 |
Nature |
Clinical genome sequencing in patients with suspected rare genetic disease in Peru |
| Oct 28, 2024 |
GenomeWeb |
Illumina's Dragen Outperforms Broad GATK, Google DeepVariant in Variant Analysis Benchmarking Study |
| Oct 25, 2024 |
Medical Device Network |
GeneDx reveals new findings from newborn genetic screening study |
| Oct 24, 2024 |
Genotipia |
La Fe Hospital in Valencia strengthens its diagnostic capacity with the NovaSeq X Plus sequencer |
| Oct 17, 2024 |
fDi Intelligence |
Illumina lights up Milan genomics |
| Oct 16, 2024 |
Genome Web |
Illumina to Offer More Pillar Cancer Panels as Part of Expanded Partnership |
| Oct 16, 2024 |
GeneOnline |
Illumina and NTU Hospital Sign Collaboration Agreement to Launch Large-Scale Whole Genome Sequencing Project |
| Oct 9, 2024 |
Reuters |
Illumina launches compact, low-cost gene sequencing devices |
| Oct 9, 2024 |
Endpoints News |
Illumina's pitch for new machines: You, too, can sequence DNA |
| Oct 9, 2024 |
GEN News |
Illumina Launches New MiSeq i100 Series with XLEAP Chemistry, RT Reagents |
| Oct 9, 2024 |
Fierce Biotech |
Illumina unveils benchtop DNA sequencer update with push-button workflows |
| Sep 26, 2024 |
China Science and Technology News Network |
Illumina Appears at the 2024 CSCO Annual Meeting, Illuminating the Future of Precision Oncology with Genomics |
| Sep 23, 2024 |
Inside Precision Heath Medicine |
Quad Moonshot First Targets Cervical Cancer |
| Sep 19, 2024 |
BioPharma APAC |
Illumina and LGC Biosearch Technologies Forge Strategic Partnership to Advance Agricultural Genomics |
| Sep 17, 2024 |
Pharmaphorum |
ESMO: Interview with Sven Schaffer |
| Sep 9, 2024 |
OncLive |
FDA Approves TruSight Oncology Comprehensive Assay As Pan-Tumor Companion Diagnostic |
| Sep 3, 2024 |
Bloomberg |
Illumina Wins Court Fight With EU Over $7 Billion Grail Deal |
| Sep 3, 2024 |
GenomeWeb |
Illumina Wins Jurisdictional Appeal in Europe Over Grail Deal, Dodges €432M Fine |
| Sep 3, 2024 |
Reuters |
Illumina wins Grail battle in blow to EU merger power |
| Aug 31, 2024 |
Indian Express |
Illumina announces global expansion plans in country, Global Capability Center to be setup in Bengaluru |
| Aug 30, 2024 |
Healthcare Radius |
Illumina expands global presence in India |
| Aug 28, 2024 |
Fierce Biotech |
FDA approves Illumina's tumor biomarker test as a pan-cancer companion diagnostic |
| Aug 28, 2024 |
The ASCO Post |
FDA Approves Cancer Biomarker Test, Companion Diagnostic Indications |
| Aug 27, 2024 |
GenomeWeb |
FDA Approves Illumina Cancer Genomic Profiling Assay as CDx for Kinase Inhibitors From Bayer, Lilly |
| Aug 27, 2024 |
Endpoints |
Illumina wins FDA approval for test to identify treatable cancers |
| Aug 16, 2024 |
Asharq Bloomberg |
King Faisal Specialist Hospital and Illumina Collaborate to Combat Rare Diseases in Saudi Arabia |
| Aug 14, 2024 |
Endpoints |
To get back to growth, Illumina CEO says it's simplifying DNA sequencing and analysis |
| Aug 13, 2024 |
PharmaBoardroom |
In Conversation: Jenny Zheng – SVP & GM of Greater China, Illumina |
| Aug 13, 2024 |
Future Lab |
Benefits and Challenges of NGS in Clinical Diagnostics |
| Aug 13, 2024 |
Reuters |
Illumina, CRISPR-pioneer Broad Institute to work on new gene sequencing kits |
| Aug 12, 2024 |
Genomics England |
100,000 whole genomes sequenced through the NHS GMS |
| Jul 29, 2024 |
21st Century Business Herald |
Unleashing the New Productivity of Gene Sequencing Technology and Casting the "Golden Key" for Industry Innovation |
| Jul 22, 2024 |
India Pharma Outlook |
Data Analytics Boosting Next-Gen Sequencing Methodologies |
| Jul 11, 2024 |
Healthcare Dive |
FDA’s lab developed test rule could be first check on agency’s power post-Chevron |
| Jul 10, 2024 |
Fierce Biotech |
Illumina buys Fluent BioSciences to better speak the language of single-cell analysis |
| Jul 10, 2024 |
BioWorld |
Illumina boldly acquires Fluent Bio weeks after Grail divestiture |
| Jun 21, 2024 |
GEN News |
StockWatch: “Final Resolution” Set for Illumina’s GRAIL Saga |
| Jun 20, 2024 |
GenomeWeb |
German Precision Medicine Model Project Gets Ready for Kickoff as Commercial Providers Cry Foul |
| Jun 13, 2024 |
Inside Precision Medicine |
Sequencing Benefits Even Low-Income Rare Disease Patients, iHope Study Shows |
| Jun 11, 2024 |
Chosun Biz |
Decoding the entire genome of a patient in 13 hours, even provides personalized treatment recommendations |
| Jun 6, 2024 |
Emirates News Agency |
Department of Health, Illumina collaborate to extend research in genomics, precision medicine |
| Jun 6, 2024 |
Genetic Alliance |
iHope shows benefits of genome sequencing across global population of genetic disease patients |
| Jun 4, 2024 |
Reuters |
Illumina's board approves to spin off Grail in June |
| Jun 4, 2024 |
San Diego Union Tribune |
San Diego gene-sequencer Illumina spins off blood testing startup Grail — for the second time |
| Jun 3, 2024 |
Fierce Pharma |
Illumina recruits Pfizer, Exact Sciences alum as new commercial chief |
| May 30, 2024 |
Pharm Executive |
Illumina Pushes Genomic Sequencing in Oncology at ASCO |
| May 30, 2024 |
GenomeWeb |
African Genomics Sector Grows Alongside Efforts to Keep Talent, Funding, Data on Continent |
| May 27, 2024 |
China News |
The Rare and Light Charity Project continues to expand its beneficiaries and bring hope to more families with rare diseases |
| May 6, 2024 |
SeqAnswers |
Recent Advances in Sequencing Analysis Tools |
| May 2, 2024 |
Scoop NZ |
Sailors To Revolutionise Our Understanding Of Pacific Biodiversity |
| May 1, 2024 |
GenomeWeb |
Illumina, Garvan Institute Jointly Invest A$27M in Single-Cell Disease Research |
| Apr 25, 2024 |
Cambridge Independent |
In pictures: Princess Anne visits Illumina at Granta Park to celebrate World DNA Day |
| Apr 25, 2024 |
Science and Technology Daily |
"Bringing Life Science to Campus” education program continues to inspire young minds for innovation |
| Apr 23, 2024 |
CAP Today |
FDA approves OncoReveal CDx on Illumina MiSeq Dx system |
| Apr 17, 2024 |
Front Line Genomics |
The $100 Genome: Where’s the Limit? |
| Apr 12, 2024 |
Reuters |
EU approves Illumina's plan to divest cancer test maker Grail |
| Apr 10, 2024 |
San Diego Union Tribune |
Illumina gets two new executives as the San Diego biotech revamps its C-suite |
| Apr 9, 2024 |
GEN News |
Best of NGS: The Instrument Companies to Watch |
| Apr 3, 2024 |
GenomeWeb |
Cancer Sequencing Labs, Advocacy Groups Partner to Increase Genetic Testing Access |
| Apr 1, 2024 |
Inside Precision Medicine |
Sequencing Spatially-Located Single Cells |
| Mar 27, 2024 |
Africa.com |
Fighting Drug Resistant TB In Africa With Genomics |
| Mar 19, 2024 |
GenomeWeb |
Global Parkinson's Genetics Program Signs up Psomagen for Large-Scale Whole-Genome Sequencing Study |
| Mar 16, 2024 |
BioSpace |
Labcorp Presents New Research Demonstrating Clinical Impact of Precision Diagnostics in Guiding Biomarker-targeted Therapies for Patients with Epithelial Ovarian Cancer |
| Mar 2, 2024 |
San Diego Union Tribune |
Volcanic explosions, lava lamps and robots entice families at San Diego’s annual science expo |
| Feb 26, 2024 |
UNC Health |
A Newborn Genetic Screening Study Reaches New Milestone |
| Feb 26, 2024 |
Yicai Global |
DNA Sequencing Giant Illumina Names Janssen Ex-Chairwoman as New SVP, China GM |
| Feb 19, 2024 |
Nature |
Super-speedy sequencing puts genomic diagnosis in the fast lane |
| Feb 12, 2024 |
Inside Precision Medicine |
AI leading the way to more precise diagnostics and disease risk prediction |
| Jan 31, 2024 |
KPBS |
San Diego researchers probe DNA sequences to help protect koalas |
| Jan 31, 2024 |
Valid News |
Ministry of Health and Illumina Develop First Genomic Engine in Indonesia |
| Jan 31, 2024 |
Kompas |
A total of 10,000 genome samples from Indonesian people will be studied |
| Jan 29, 2024 |
Straits Times |
Project to map DNA of 100,000 people in Singapore at halfway mark |
| Jan 24, 2024 |
GenomeWeb |
German Children's Cancer Center Aims to Expand Global Access to Methylation-Based Tumor Classifier |
| Jan 16, 2024 |
San Diego Union Tribune |
Illumina and the San Diego Zoo are sequencing koala genomes to investigate disease |
| Jan 16, 2024 |
GEN News |
Inexpensive Sequencing Is Enabling the Age of Multiomics |
| Jan 16, 2024 |
GenomeWeb |
Illumina, Ginkgo Bioworks Ink Global Comarketing Agreement for Biosecurity |
| Jan 15, 2024 |
News-Medical.Net |
Pioneering Genomic Progress: An Interview with Rami Mehio, Illumina's Software and Informatics Expert |
| Jan 12, 2024 |
GEN News |
What Will 2024 Mean for NGS and Genomics? |
| Jan 10, 2024 |
New York Times |
Ancient Skeletons Give Clues to Modern Medical Mysteries |
| Jan 10, 2024 |
The Sacramento Bee |
Koalas are threatened by diseases with ‘devastating effects.’ San Diego Zoo has a plan |
| Jan 5, 2024 |
GenomeWeb |
Illumina, Janssen to Collaborate on Molecular Residual Disease Liquid Biopsy Test |
| Jan 5, 2024 |
APM News |
Illumina appoints Caroline Thureau to lead its operations in France |
| Jan 4, 2024 |
BioSpace |
The Alliance for Genomic Discovery welcomes Bristol Myers Squibb, GSK, and Novo Nordisk |
| Dec 29, 2023 |
Korea Biomedical Review |
Illumina celebrates 25 Years of transformative impact in genomics |
| Dec 15, 2023 |
Africa.com |
ASLM And Illumina Sign MOU To Increase Access To Genomics To Fight Infectious Diseases In Africa |
| Dec 13, 2023 |
BioCentury |
Illumina lowers access barriers to pathogen surveillance |
| Dec 12, 2023 |
GenomeWeb |
Illumina Partners with HaploX to Offer Domestically Produced Sequencers in China |
| Dec 4, 2023 |
San Diego Business Journal |
Illumina Continues to Dominate the NGS Market |
| Nov 30, 2023 |
GEN News |
UK Biobank Releases Whole Genome Data from Half a Million People |
| Nov 30, 2023 |
Cambridge Independent |
City MP drops by as CoFarm tops £100k of food distributed |
| Nov 29, 2023 |
Gulf Daily News |
Bahrain becomes first country in the Middle East to acquire and inaugurate cutting-edge machine for human genome sequencing |
| Nov 29, 2023 |
GenomeWeb |
Comparison of 239 Primate Genomes Reveals Conserved Regulatory Sequences |
| Nov 14, 2023 |
GEN News |
Pathogen Sequencing Tools Brought to Low Income Countries by Illumina Initiative |
| Nov 14, 2023 |
Baidu Post |
Novogene purchases 10 additional NovaSeq™ X Plus units to help upgrade global service capabilities |
| Nov 8, 2023 |
GenomeWeb |
Veracyte Taps Illumina to Develop Sequencing-Based IVDs as LDT Sales Continue Growth in Q3 |
| Nov 7, 2023 |
GEN News |
NGS Sample Prep: Enduring Basics and Evolving Enzyme Kits |
| Nov 6, 2023 |
BioWorld |
Illumina releases liquid biopsy for genomic profiling of tumors |
| Nov 2, 2023 |
Clinical Lab Product |
Illumina Unveils Liquid Biopsy Assays for Comprehensive Genomic Profiling of Solid Tumors |
| Nov 1, 2023 |
Korea Medical News |
Illumina, 25th Anniversary “Improving Genome Sequencing Accessibility” |
| Sep 22, 2023 |
MedCity News |
How Genome Sequencing Can Broaden the Scope of Newborn Screening |
| Sep 22, 2023 |
CareNet |
Cancer gene panel testing, more, faster/Illumina |
| Sep 20, 2023 |
Harvard |
Botswana lab known for identifying Omicron variant receives new recognition |
| Sep 19, 2023 |
BioSpace |
Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials |
| Sep 10, 2023 |
ABC News |
VIDEO: Australia's most sustainable cows |
| Sep 5, 2023 |
The Wall Street Journal |
Illumina Names Jacob Thaysen as New CEO |
| Aug 29, 2023 |
BBC News |
Machine tests genetic information in 24 hours |
| Aug 17, 2023 |
Business Standard |
San Diego-based biotech company Illumina bets on India for growth |
| Jul 26, 2023 |
Medical Device Network |
Illumina and Pillar collaborate to commercialise oncology assays |
| Jul 20, 2023 |
Biocompare |
Selecting the Right NGS Method |
| Jul 19, 2023 |
Genetic Engineering and Biotechnology News |
Alliance for Genomic Discovery Announces Five Founding Biopharma Members |
| Jun 12, 2023 |
GenomeWeb |
ESHG: German Study Shows Utility of Rapid Whole-Genome Trio Sequencing in Critically Ill Children |
| Jun 3, 2023 |
Fierce Biotech |
ASCO: Illumina's oncology exec on the need to 'democratize genomic profiling in cancer' |
| Jun 1, 2023 |
The Washington Post |
New AI tool searches genetic haystacks to find disease-causing variants |
| Jun 1, 2023 |
Science |
Hundreds of new primate genomes offer window into human health—and our past |
| May 12, 2023 |
CNBC |
Leaders Speak: Illumina Asia-Pac medical head on the expanded scope of precision medicine in AI era |
| May 11, 2023 |
Bio-ITWorld |
Illumina Relaunches Correlation Engine, Banking on Need for ‘Omics Informatics Tools |
| May 8, 2023 |
Biocompare |
How MCEDS Are Changing the Game in Cancer Detection |
| Apr 27, 2023 |
Biologiste365 |
Towards the $200 genome |
| Apr 25, 2023 |
ITVX |
Blood test for lung cancer could speed up diagnosis in Wales as trial launched |
| Apr 13, 2023 |
Devex |
The African continent ramps up efforts to crack the code on outbreaks |
| Apr 11, 2023 |
Inside Precision Medicine |
Illumina, Henry Ford Health Partner to Study Impact of CGP on Cardiovascular Disease |
| Mar 31, 2023 |
HealthAffairs |
Thinking Differently About Multicancer Early Detection Screening Tests |
| Mar 24, 2023 |
IDN Times |
Illumina Launches Tool for Detection of Drug-Resistant Tuberculosis |
| Mar 20, 2023 |
CNN International |
100,000 newborn babies will have their genomes sequenced in the UK. It could have big implications for child medicine |
| Mar 14, 2023 |
TechnologieBox |
CeGaT is one of the first companies worldwide to receive the most powerful sequencing platform NovaSeq™ X Plus |
| Mar 8, 2023 |
Diagnostics World |
Illumina, Myriad Partner To Release HRD Test |
| Mar 6, 2023 |
Korea Biomedical Review |
Macrogen installs Illumina’s latest production-scale sequencer |
| Feb 22, 2023 |
Savoy Network |
Illumina: Expanding the DEI Blueprint to Drive Change |
| Feb 20, 2023 |
Nature |
Innovative technologies crowd the short-read sequencing market |
| Feb 4, 2023 |
Fortune |
Cancer vaccines are already a reality—but your doctor might not tell you about them unless you ask |
| Jan 19, 2023 |
CNBC |
Illumina CEO: Genomics in children’s hospitals will be the biggest part of the market |
| Jan 12, 2023 |
Bio-ITWorld |
At J.P. Morgan Illumina Reports Record-Breaking Uptake of NovaSeq X, Expanding Sequencing Market |
| Jan 10, 2023 |
Genetic Engineering & Biotechnology News |
At JPM, Illumina Announces African-American Sequencing Collaboration |
| Jan 3, 2023 |
Inside Precision Medicine |
Digging Deep to Release the Power of the Proteome |
| Dec 30, 2022 |
Financial Times |
UK to embark on groundbreaking new genomics projects |
| Nov 21, 2022 |
GenomeWeb |
Illumina, Al Jalila Children's Specialty Hospital Ink Rapid Whole-Genome Sequencing Deal |
| Nov 21, 2022 |
CSR Wire |
Q&A With the CTO: Storing Growing Data While Reducing Environmental Impact |
| Nov 12, 2022 |
The National |
New Dubai centre aims to shed light on genetic aspects of disease in the Middle East |
| Nov 10, 2022 |
HarryGlorikian |
Episode 100! Illumina’s Phil Febbo On The New Era Of Low-Cost Genome Sequencing |
| Oct 18, 2022 |
GenomeWeb |
Illumina, GenoScreen Partner to Comarket Genomic Testing for Multidrug-Resistant TB |
| Oct 11, 2022 |
Fierce Biotech |
Illumina joins with AstraZeneca on AI-driven drug discovery project |
| Sep 30, 2022 |
Fierce Biotech |
Illumina pitches $200 genomes with new line of DNA sequencers |
| Sep 29, 2022 |
Genetic Engineering and Biotechnology News |
At Illumina Genomics Forum, Obama Prescribes Diversity, Resilience to Drive Precision Medicine into Practice |
| Sep 14, 2022 |
GenomeWeb |
Illumina Accelerator Invests in Six New Startups |
| Aug 25, 2022 |
FS Sustainability |
Minderoo Foundation, Illumina launch ocean biodiversity DNA project |
| Aug 14, 2022 |
Time |
Illumina Helped the World Fight COVID-19. Now, CEO Francis deSouza Has Monkeypox in His Sights |
| Jul 27, 2022 |
The National |
Hi-tech genetic sequencing at Dubai children's hospital aims to improve patient care |
| Jul 27, 2022 |
GenomeWeb |
Illumina Dragen v4.0 |
| Jul 25, 2022 |
Vanguard |
IITA scientist breeds more resilient yam species in West Africa |
| Jul 13, 2022 |
Business Weekly |
Ovarian cancer pioneer builds on Illumina Accelerator success |
| Jun 28, 2022 |
Business Weekly |
Cambridge payback as Illumina invests in £30m genomics venture fund |
| Jun 28, 2022 |
Genome Web |
Illumina Invests in UK-Based Genomics Venture Fund Tied to Startup Accelerator Program |
| Jun 28, 2022 |
CSR Egypt |
Illumina hails Egypt’s aspirations for utilizing genomics in healthcare issues |
| Jun 17, 2022 |
Biotech Dispatch |
Illumina's Susan Tousi on genomics and changing healthcare |
| Jun 16, 2022 |
Business Weekly |
Illumina toasts Accelerator success in Cambridge |
| Jun 9, 2022 |
Targeted Oncology |
New Pan-Cancer CDx Added to the TruSight Oncology Test |
| Jun 5, 2022 |
STAT |
Illumina, maker of a key tool for drug discovery, to try making new drugs itself |
| May 26, 2022 |
Channel News Asia |
DNA of 100,000 Singaporeans to be sequenced, analysed to improve population health |
| May 24, 2022 |
Fierce Biotech |
Illumina obtains European companion diagnostic test approval for Bayer rare cancer drug Vitrakvi |
| May 24, 2022 |
Genome Web |
Illumina Adds CDx Indication to European TruSight Oncology Test for NTRK Gene Fusion Detection |
| May 6, 2022 |
Fierce Biotech |
Illumina steps deeper into drug discovery with Deerfield, Janssen partnerships |
| Apr 25, 2022 |
Nature Biotechnology |
Baby’s first genome |
| Apr 25, 2022 |
Genome Web |
Illumina, Germany's Hannover Medical School Collaborate on WGS for Critically Ill Newborns |
| Apr 19, 2022 |
Inside Precision Medicine |
Growing Pains |
| Apr 19, 2022 |
Bloomberg |
World Must Leverage Genomics to Fight Pandemics, Illumina CEO Says |
| Apr 12, 2022 |
Hälsa |
Pilot Projects Have Begun With a Broad Analysis of the Genome in the Fight Against Cancer Tumors |
| Apr 8, 2022 |
Inside Precision Medicine |
Comprehensive Genomic Profiling (CGP) has the Promise to be a Game-Changer to In form Precision Oncology, but Hurdles Remain |
| Apr 4, 2022 |
Business Today |
AGTC Genomics Links-up with Illumina to Unveil World-leading Genome Sequencing Technology |
| Mar 18, 2022 |
The Wall Street Journal |
Illumina Names New CIO to Increase Its IT Agility |
| Mar 17, 2022 |
Genome Web |
UK Researchers Aim to Discern New Polygenic Risk Scores from 5 Million Genotypes |
| Mar 17, 2022 |
San Diego Metro Magazine |
Illumina Accelerator invests in seven additional genomics startups |
| Mar 16, 2022 |
Fierce Biotech |
Illumina launches cancer profiling diagnostic in Europe |
| Mar 16, 2022 |
Genome Web |
Illumina Accelerator Invests in Seven Additional Genomics Startups |
| Mar 15, 2022 |
Reuters |
Illumina launches multiple-gene test to spot rare treatable cancers |
| Mar 14, 2022 |
The Times of India |
Illumina, Trivitron join hands to accelerate disease detection, diagnosis |
| Mar 14, 2022 |
Express Healthcare |
Illumina and Trivitron partner to accelerate disease detection and diagnosis for patients in India |
| Mar 8, 2022 |
Fast Company |
The 10 most innovative health companies of 2022 |
| Feb 28, 2022 |
Calcalist |
DNA sequencing giant Illumina to establish Center of Excellence in Israel |
| Feb 10, 2022 |
San Diego Union Tribune |
Illumina rings up strong financial results, updates antitrust probe of Grail acquisition |
| Feb 10, 2022 |
Barron's |
Illumina’s Sales Grew, But Biotech Investors Are Hard to Impress |
| Jan 21, 2022 |
BioCentury |
Illumina deal takes Agendia’s tests directly to hospitals |
| Jan 21, 2022 |
GenomeWeb |
SomaLogic's Illumina Codevelopment Deal Suggests Future of Label-Based Proteomics Lies in NGS |
| Jan 16, 2022 |
Financial Times |
Illumina says EU probe of $8bn Grail deal could hit biotech investment |
| Jan 12, 2022 |
El Pais |
A blood test allows to predict the main complication of pregnancy before it appears |
| Jan 12, 2022 |
Bloomberg |
Illumina’s CEO Says Increasing Access to Testing Has Lifted Sales |
| Jan 11, 2022 |
Barron's |
Illumina Raises Revenue Forecast as Gene Sequencing Business is Booming |
| Jan 11, 2022 |
BioIT World |
Illumina Teases New Chemistry, Long Reads, Oncology, Proteomics Partnerships |
| Jan 10, 2022 |
Bloomberg Law |
Illumina to Develop DNA Tech Sought in Failed PacBio Deal |
| Jan 10, 2022 |
Fierce Biotech |
JPM 2022: Illumina posts new sales records, lays out long-read chemistry plans |
| Jan 10, 2022 |
Reuters |
Illumina forecasts strong 2022 revenue, signs four partnership deals |
| Jan 10, 2022 |
CNBC Fast Money |
Illumina CEO joins Fast Money from the JPM Health Care Conference |
| Jan 5, 2022 |
GenomeWeb |
Illumina, SomaLogic Ink Codevelopment Agreement for Proteomics Assays With Sequencing Readout |
| Jan 1, 2022 |
Cambridge Independent |
Illumina’s Dr David Bentley made OBE in New Year Honours 2022 for genomics expertise |
| Dec 21, 2021 |
Corriere della Sera |
Milan, in the Mind area, the Californian company Illumina arrives: fifth company in the ex Expo village |
| Dec 21, 2021 |
Wisconsin State Journal |
Key materials for genome sequencing made at Illumina in Madison |
| Dec 16, 2021 |
The Philadelphia Inquirer |
Philadelphia’s ability to track COVID-19 variants — and the nation’s — is hobbled by a lack of resources |
| Dec 9, 2021 |
MedCity News |
As genetic testing expands, evidence and awareness needed to spur adoption |
| Dec 6, 2021 |
Leaps.org |
Researchers Are Discovering How to Predict – and Maybe Treat — Pregnancy Complications Early On. |
| Dec 5, 2021 |
CBS Face the Nation |
Illumina CEO explains what scientists are studying to determine if Omicron variant is more transmissible |
| Dec 2, 2021 |
FOX 5 San Diego |
1st U.S. Omicron Case Detected In California |
| Nov 30, 2021 |
Politico |
Testing labs brace for first U.S. cases of Omicron |
| Nov 30, 2021 |
ABC Channel 10 |
Scientist rushing to learn more about Omicron COVID-19 variant |
| Nov 29, 2021 |
Bloomberg |
Omicron Undetected in U.S. So Far, Testing Biden Sequencing Plan |
| Nov 23, 2021 |
BioCentury |
Illumina to scale-up philanthropic sequencing with $120M investment |
| Nov 16, 2021 |
Shanghai Daily |
Shanghai continues to invest in pharmaceutical industry and technology |
| Nov 12, 2021 |
Science Board |
Illumina for Startups pushes boundaries of genomics by supporting early-stage companies |
| Nov 7, 2021 |
Barron's |
Illumina’s Genetic Testing Business is Booming |
| Nov 4, 2021 |
Frontline Genomics |
ESG in Genomics: Where to start? – Interview with Sharon Vidal, Senior Director and Global Lead for Corporate Social Responsibility at Illumina |
| Oct 29, 2021 |
Cambridge Independent |
Climate change caused extinction of woolly mammoths, University of Cambridge scientists prove |
| Oct 27, 2021 |
GenomeWeb |
Illumina, Israel Ministry of Health to Pilot Genome Sequencing for Diagnosing Critically Ill Infants |
| Oct 26, 2021 |
Disrupt Africa |
SA AI-based biotech startup BixBio raises funding from Illumina Accelerator |
| Oct 25, 2021 |
Emerging Europe |
Made in emerging Europe: Bob Concierge, Resistant AI, Orgnostic, AerinX, Genegoggle, Nooka Space |
| Oct 21, 2021 |
Tech in Africa |
SA biotech startup BixBio among seven genomics companies to receive investment from the Illumina Accelerator |
| Oct 7, 2021 |
Cambridge Independent |
Illumina offers insight into world of DNA sequencing for 35 interns at Granta Park |
| Oct 5, 2021 |
Bloomberg |
Illumina, Invesco Execs on Investing in Innovation |
| Sep 27, 2021 |
Medpage Today |
Whole Genome Sequencing in Babies Proves Mettle |
| Sep 27, 2021 |
ClinicalOMICs |
Early Genome Sequencing Improves Care for Critically Ill Infants |
| Sep 20, 2021 |
Yahoo Finance |
Illumina Begins Climate Week by Highlighting How Sequencing Supports Resilient Responses to Climate Change |
| Sep 15, 2021 |
Genome Web |
Illumina Adds Seven Genomics Startups to Accelerator Program |
| Sep 9, 2021 |
APN News |
Illumina Commits to Net Zero Global Greenhouse Gas Emissions by 2050 |
| Sep 8, 2021 |
Fierce Biotech |
Merck taps Illumina to develop companion diagnostics for ovarian cancer treatments |
| Aug 14, 2021 |
Motley Fool |
Illumina Delivers a Beat and a Raise in Q2 |
| Aug 12, 2021 |
Reuters |
EU regulators pause investigation into Illumina, Grail deal |
| Aug 10, 2021 |
Bío Bío |
Centro de investigación realiza primera secuenciación masiva de nuevas variantes de covid en Bío Bío |
| Aug 10, 2021 |
Technology Networks |
Sustainability Grant Awarded to Honey Bee Research |
| Aug 9, 2021 |
San Diego Union Tribune |
Riding high on record revenue, Illumina hopes to acquire Grail by year’s end |
| Aug 6, 2021 |
Fierce Biotech |
Illumina posts 78% revenue growth as cancer, DNA testing ramp back up |
| Aug 5, 2021 |
Times of India |
Mumbai gets its first genome lab to strengthen fight against Covid |
| Jul 29, 2021 |
AP |
COVID-19 variants tested through genome sequencing |
| Jul 28, 2021 |
USA TODAY |
Opinion: This new test for cancer could save your life. Here's why you can't get it. |
| Jul 27, 2021 |
SeekingAlpha |
Illumina: Not All Rests With The Grail Acquisition |
| Jul 26, 2021 |
Washington Times |
Biden’s FTC threatens defense industry with increased meddling |
| Jul 25, 2021 |
MedCity News |
Opinion: Would Illumina’s acquisition of GRAIL constrict the expansion of the liquid biopsy space? |
| Jul 22, 2021 |
SD Union Tribune |
Will Illumina pull off its $7.1B bid to acquire Grail? EU regulators may have final say |
| Jul 22, 2021 |
Reuters |
Illumina deal for Grail could hurt innovation, EU warns |
| Jul 20, 2021 |
YahooFinance |
Illumina Wins Reddot 2021 Award: Genomic Sequencing System NextSeq 1000/2000 |
| Jul 20, 2021 |
YahooFinance |
Can Illumina (ILMN) Keep the Earnings Surprise Streak Alive? |
| Jul 14, 2021 |
GenomeWeb |
Illumina, Sanigen Partner on NGS-Based Food Safety Testing in South Korea |
| Jul 13, 2021 |
Reuters |
Illumina, Grail deal faces full-scale EU antitrust probe – according to sources |
| Jul 6, 2021 |
mLex |
Illumina-Grail review sees EU regulator weighing matters of life and death |
| Jul 6, 2021 |
USA TODAY |
Opinion: Medical merger could improve cancer treatment for minorities. So why is FTC blocking it? |
| Jul 5, 2021 |
Bloomberg |
Is a Blood Test for Multiple Cancers Hope or Hype? |
| Jun 27, 2021 |
Forbes |
Regulators And Vertical Mergers: The Case Of The Cancer-Detection Companies Seeking To Re-Merge |
| Jun 23, 2021 |
National Law Review |
Illuminating Vertical Merger Challenges: FTC Challenges Illumina’s Reacquisition of a Nascent Company it Founded |
| Jun 23, 2021 |
TechRadar |
DNA storage is the most important innovation you’ve never heard about |
| Jun 17, 2021 |
Reuters |
EU antitrust regulators set July 27 deadline for Illumina, Grail deal |
| Jun 14, 2021 |
Texas Monthly |
Pecos Jane Has a Name |
| Jun 11, 2021 |
San Diego Union-Tribune |
Can robots speed up drug discovery? San Diego firm’s software helps labs embrace automation |
| Jun 11, 2021 |
TIME |
What We Learned About Genetic Sequencing During COVID-19 Could Revolutionize Public Health |
| Jun 11, 2021 |
SD Union Tribune |
Can robots speed up drug discovery? San Diego firm’s software helps labs embrace automation |
| Jun 9, 2021 |
Newsweek |
Ceding Regulatory Power to the EU Risks U.S. Prosperity and Sovereignty |
| Jun 2, 2021 |
Omics! Omics! |
New Clinical Human Genome Speed Record |
| Jun 1, 2021 |
NASDAQ |
Illumina (ILMN) Expands NIPT Offering With New Collaboration |
| Jun 1, 2021 |
STAT |
Researchers claim they have sequenced the entirety of the human genome — including the missing parts |
| May 27, 2021 |
Cambridge Independent |
Dreamt up over a pint at the Panton Arms: Cambridge chemists tell astonishing story of DNA sequencing after 1m euro prize |
| May 25, 2021 |
NASDAQ |
Is Illumina (ILMN) Outperforming Other Medical Stocks This Year? |
| May 24, 2021 |
GenomeWeb |
Illumina, Microba Life Sciences Partner on Human Gut Microbiome Research |
| May 10, 2021 |
San Diego Business Journal |
Industry Looks at Ways to Sustain Growth After Pandemic |
| May 10, 2021 |
KUSI Television (San Diego) |
FTC jeopardizes chance to save lives from cancer, says Illumina CMO |
| May 3, 2021 |
Seeking Alpha |
Illumina: A Highly Valued Play In Genetic Sequencing |
| Apr 30, 2021 |
Medtech Dive |
Illumina sues European Commission to block competition probe into Grail buyout |
| Apr 30, 2021 |
Socal Tech |
Illumina Donates $60M To Pathogen Genomics Effort |
| Apr 29, 2021 |
Fierce Biotech |
Illumina sues European Commission to stop investigation of $8B Grail acquisition |
| Apr 29, 2021 |
GenomeWeb |
Illumina Challenges European Commission's Jurisdiction Over Review of Grail Acquisition in EU General Court |
| Apr 29, 2021 |
Times of San Diego |
Illumina Donates $60 Million in Genetic Sequencing to Increase Global Tracking of New Pathogens |
| Apr 29, 2021 |
ITP.net |
Illumina to donate $60 million in sequencing capabilities to a global initiative |
| Apr 28, 2021 |
GenomeWeb |
Illumina, GeneDx Partner With University of Washington on Whole-Genome Sequencing Study in Kids |
| Apr 28, 2021 |
The Motley Fool |
How Illumina's Q1 Results Delighted Investors |
| Apr 28, 2021 |
Fierce Biotech |
Illumina pledges $60M in genomic sequencing expertise to help launch global outbreak-tracking network |
| Apr 27, 2021 |
Seeking Alpha |
Illumina beats consensus with Q1 results as topline growth accelerates |
| Apr 27, 2021 |
Investor's Business Daily |
Illumina Rises On Quarterly Beat, Strong Outlook; Reaffirms Grail Buyout |
| Apr 27, 2021 |
TIME Magazine |
2021 TIME100 Most Influential Companies: Illumina - Decoding COVID-19 |
| Apr 23, 2021 |
Benzinga |
Illumina, Kartos Therapeutics Team Up To Develop Companion Diagnostic For TP53-Haboring Cancer Indications |
| Apr 23, 2021 |
Fierce Biotech |
Illumina to move its oncology assay into blood-based cancers with companion diagnostic partnership |
| Apr 22, 2021 |
GenomeWeb |
Illumina, Kartos Therapeutics Partner to Develop TP53 Companion Diagnostic |
| Apr 22, 2021 |
Seeking Alpha |
Illumina, Kartos partner to develop hematologic companion diagnostic |
| Apr 20, 2021 |
Reuters |
EU to examine Illumina's $7.1 billion acquisition of Grail on antitrust grounds |
| Apr 14, 2021 |
Sky News (Australia) |
Genomic sequencing changing rate of vaccine development |
| Apr 10, 2021 |
Axios |
Illumina CEO on a genomics-forward future |
| Apr 8, 2021 |
Reuters |
Illumina CEO says GRAIL deal is good for competition |
| Apr 6, 2021 |
CNBC Squawk Box |
Illumina CEO Francis deSouza on first-quarter results, outlook and more |
| Apr 6, 2021 |
Yahoo Money |
Illumina expects to top $1 billion in revenue |
| Apr 2, 2021 |
GenomeWeb |
Illumina Parries FTC Challenge to Grail Acquisition With Deals for Competing Customers |
| Mar 31, 2021 |
Forbes |
Rapid Genome Sequencing Can Save Babies With Rare Diseases, If They Can Get It |
| Mar 31, 2021 |
Fierce Biotech |
FTC aims to thwart Illumina's multibillion-dollar quest for Grail |
| Mar 31, 2021 |
Genetic Engineering & Biotechnology News |
Illumina Vows to Fight Back as FTC Takes Aim at $8B Grail Acquisition |
| Mar 31, 2021 |
BioWorld |
FTC throws up antitrust hurdle to Illumina’s planned acquisition of Grail |
| Mar 30, 2021 |
MedCity News |
Illumina’s $7.1B Grail buyout is challenged by FTC on competitive grounds |
| Mar 30, 2021 |
BioSpace |
Antitrust Concerns Hinder Second Illumina Acquisition, FTC Raises Concern Over $8 Billion Deal for Grail |
| Mar 30, 2021 |
Mass Device |
Illumina vows to pursue Grail purchase despite FTC challenge |
| Mar 30, 2021 |
Reuters |
U.S. seeks to stop Illumina from purchasing cancer-testing firm Grail |
| Mar 25, 2021 |
New York Times |
Scientists can now sequence an entire genome overnight. |
| Mar 24, 2021 |
KSWB-TV Fox (San Diego) |
New coronavirus variant detected in San Diego for 1st time |
| Mar 16, 2021 |
GenomeWeb |
Illumina, Geneseeq Technology to Collaborate on IVD Cancer Testing Kits in China |
| Mar 16, 2021 |
Seeking Alpha |
illumina inks deal with Geneseeq for in-vitro diagnostic NGS kit in china |
| Mar 14, 2021 |
Bariloche 2000 (Argentina) |
Una barilochense integra el equipo que desarrolló instrumento para monitorear mutaciones del coronavirus |
| Mar 11, 2021 |
Devex |
Exclusive: Quarter of world's countries haven’t tracked COVID-19 mutations |
| Mar 10, 2021 |
ABC News 10 (San Diego) |
San Diego companies behind several major advances in the fight against COVID-19 |
| Mar 5, 2021 |
GenomeWeb |
Illumina Receives Medical Device Registration in Russia for NextSeq 550 Dx Sequencer, Reagents |
| Mar 5, 2021 |
ClinicalOMICs |
Illumina Granted Registration in Russia for Clinical NGS Platform, Reagents |
| Mar 4, 2021 |
Tele Z (Switzerland) |
Wie Entstehen Coronavirus-Mutationen? |
| Feb 26, 2021 |
Investor's Business Daily |
Coronavirus Mutations: Why The Battle Against Covid Is Just Beginning |
| Feb 25, 2021 |
Kaiser Health News |
Have a Case of a Covid Variant? No One Is Going to Tell You |
| Feb 25, 2021 |
BioPharma Reporter |
German program using whole genome sequencing to diagnose rare diseases and cancer risk |
| Feb 17, 2021 |
Cambridge Independent |
Illumina Accelerator Cambridge announces four chosen genomics start-ups and £20m match-funding pledge |
| Feb 17, 2021 |
Bloomberg Technology |
Illumina's deSouza on Tech Growth and Need for a Bio Force |
| Feb 17, 2021 |
Associated Press |
Government rushes virus gene-mapping as mutations spread |
| Feb 16, 2021 |
Dallas Innovates |
‘Highly Selective’ Illumina Accelerator Picks Dallas-Based Doloromics for its Second Funding Cycle |
| Feb 12, 2021 |
CNBC Squawk Box |
Illumina CEO on the hunt to find Covid-19 variants |
| Feb 12, 2021 |
GenomeWeb |
NovaSeq, China Instrument Sales Help Illumina Get NGS Business Back on Track in Q4 |
| Feb 12, 2021 |
ABC 10 News (San Diego) |
In-Depth: Breaking down the COVID-19 variants |
| Feb 11, 2021 |
BioWorld |
Industry, universities unite to scale up surveillance of SARS-CoV-2 variants |
| Feb 9, 2021 |
Science |
U.S. rushes to fill void in viral sequencing as worrisome coronavirus variants spread |
| Feb 9, 2021 |
ABC 10 News (San Diego) |
As COVID-19 variants surge, San Diego's Illumina leads race in discovering dangerous mutations |
| Feb 8, 2021 |
Semana (Argentina) |
Argentina detecta casos de variantes del coronavirus |
| Feb 8, 2021 |
Business Weekly (Cambridge, UK) |
£20m boost as Illumina unveils more genomics startups for Cambridge and US accelerator |
| Feb 8, 2021 |
MD+DI |
Genomics Leader Illumina Revs up Its Company Creation Engine |
| Feb 8, 2021 |
GenomeWeb |
Illumina Adds Nine Startups to Accelerator Program, Announces £20M Matching Fund |
| Feb 6, 2021 |
ProPublica |
Why Opening Restaurants Is Exactly What the Coronavirus Wants Us to Do |
| Feb 6, 2021 |
Perfil (Argentina) |
Llegó al Malbrán el 'CovidSeq', secuenciador que permite "vigilar" al Covid-19 |
| Feb 6, 2021 |
El Tiempo (Argentina) |
Argentina adquiere una máquina para detectar mutaciones del covid-19 |
| Feb 4, 2021 |
GenomeWeb |
Belgian Society of Medical Oncology to Study Value of Genomic Profiling for Cancer Patients |
| Feb 4, 2021 |
FinancialDirector |
Illumina CFO on using genome tech to beat pandemic |
| Feb 4, 2021 |
BioPharma Reporter |
Belgian trial to evaluate potential of genomic profiling of a patient’s cancer to guide personalized treatment options |
| Feb 4, 2021 |
Precision Oncology News |
Belgian Society of Medical Oncology to Study Value of Genomic Profiling for Cancer Patients |
| Feb 3, 2021 |
Genetic Engineering & Biotechnology News |
Genomic Visions: Where Are We Now? |
| Feb 2, 2021 |
The Guardian |
'We were in the dark': why the US is far behind in tracking Covid-19 variants |
| Feb 1, 2021 |
BioSpace |
Illumina Partners with Sequoia Capital for its 3rd Life Science Incubator, This One in China |
| Feb 1, 2021 |
Fierce Biotech |
Illumina, Sequoia Capital launch genomics startup incubator in China |
| Feb 1, 2021 |
Seeking Alpha |
Illumina surges after patent win; announces collaboration in China |
| Jan 31, 2021 |
GenomeWeb |
Illumina, Sequoia Capital China Partner on Genomics Incubator in China |
| Jan 31, 2021 |
Times of San Diego |
Illumina Launches Startup Incubator in China, With Funding to Open in Fall |
| Jan 29, 2021 |
Washington Post |
Why America is ‘flying blind’ to the coronavirus mutations racing across the globe |
| Jan 29, 2021 |
GenomeWeb |
Genomics England Preps for NHS Genomic Medicines Service Launch With New Focus, Tools |
| Jan 26, 2021 |
Genetic Engineering and Biotechnology World |
New Genome Sequencing Lab Unveiled in Lagos, Nigeria |
| Jan 25, 2021 |
Tagesschau Daily News (Germany) |
Illumina’s NovaSeq 6000 appears in Tagesschau daily news (Germany) |
| Jan 22, 2021 |
CNBC Squawk Box Program |
‘Chances are high’ the South African Covid variant is in the US: Illumina CEO |
| Jan 22, 2021 |
Facing Forward with Margaret Brennan |
Facing Forward podcast interview with Illumina CEO, Francis deSouza |
| Jan 22, 2021 |
Fierce Biotech |
Illumina CEO says U.S. lags behind on catching COVID-19 mutations: CNBC |
| Jan 20, 2021 |
GenomeWeb |
Illumina Wins UK Patent Infringement Suit Against BGI, Affiliates |
| Jan 18, 2021 |
Channel 5 (Fox) - San Diego |
Strain linked to Bay Area outbreaks detected statewide, including in San Diego County |
| Jan 16, 2021 |
CBS News |
U.S. races to catch up with other countries in COVID-19 sequencing research |
| Jan 15, 2021 |
NBC News |
Inside a UK lab tracking Covid variants |
| Jan 15, 2021 |
MarketWatch |
Fear of new virus variant pushes U.S. toward more genomic sequencing |
| Jan 14, 2021 |
Wall Street Journal (video) |
The Coronavirus Is Mutating. Here’s What We Know |
| Jan 13, 2021 |
Clinical Lab Products |
Myriad Genetics, Illumina Form Strategic Partnership in Oncology |
| Jan 13, 2021 |
Clinical Lab Products |
Illumina Partners with 4 Companies to Advance Genomic Profiling for Oncology |
| Jan 12, 2021 |
Fierce Biotech |
JPM: Illumina inks multiple cancer diagnostic partnerships to complement upcoming Grail acquisition |
| Jan 11, 2021 |
Bio-IT World |
Illumina at JPM: Cloud Analytics Platform, More Diagnostics Focus, Sequencing Updates To Come |
| Jan 11, 2021 |
CNBC Closing Bell |
Illumina CEO on 2021 outlook and tracking new coronavirus strains |
| Jan 11, 2021 |
MedCity News |
Illumina, Helix track spread of more contagious coronavirus variant |
| Jan 11, 2021 |
FirstWord MEDTECH |
Illumina to launch new bioinformatics solution |
| Jan 11, 2021 |
Precision Oncology News |
Multi-Cancer Molecular Screening Assays Primed for Clinical Implementation in 2021 |
| Jan 11, 2021 |
GenomeWeb |
Illumina CEO Discusses Pan-Cancer IVD Assay, CDx Collaborations at JP Morgan |
| Jan 11, 2021 |
Seeking Alpha |
Illumina announces strategic partnership with BMY, KURA, MYGN and Merck to advance comprehensive genomic profiling; provides 2021 guidance |
| Jan 8, 2021 |
GenomeWeb |
COVID-19 Mutations Present Unexpected Opportunities, Challenges for Molecular Diagnostic Developers |
| Jan 8, 2021 |
Channel 7 News (CBS - Bay Area) |
Bay Area company Helix tracking areas where new COVID-19 variant is spreading |
| Jan 8, 2021 |
Wired |
How Fast Can Scientists Find the New Coronavirus Strains? |
| Jan 7, 2021 |
WebMD |
New COVID ‘Super Strains’ Could Disrupt Life Again |
| Jan 6, 2021 |
New York Times |
U.S. Is Blind to Contagious New Virus Variant, Scientists Warn |
| Jan 6, 2021 |
Precision Vaccination |
Collaboration Launches to Assess the Prevalence of Coronavirus Variant |
| Jan 5, 2021 |
Channel 5 (Fox) - San Diego |
32 cases of new COVID-19 strain identified in San Diego County |
| Jan 5, 2021 |
Channel 8 (CBS) - San Diego |
32 COVID-19 variant cases now identified in San Diego County |
| Jan 5, 2021 |
WebMD |
CDC Hopes to Double Tests for New COVID Variants |
| Jan 5, 2021 |
Times of San Diego |
San Diego’s Illumina Announces Collaboration to Identify COVID-19 Variants |
| Jan 5, 2021 |
GenomeWeb |
Illumina, Helix Collaborate on CDC-Coordinated Coronavirus Surveillance |
| Jan 5, 2021 |
GenomeWeb |
New York Study Aims to Assess Utility of Clinical Whole-Genome Sequencing Across Diseases |
| Jan 4, 2021 |
BFM Television (Lyon, France) |
Covid-19 : le variant du virus étudié à Lyon |
| Dec 17, 2020 |
Genetic Engineering & Biotechnology News |
Illumina, Emedgene Launch AI-Based Rare Disease Interpretation Partnership |
| Dec 16, 2020 |
GenomeWeb |
Illumina, Emedgene Partner on Automated Genomic Data Interpretation |
| Dec 16, 2020 |
Bio-IT World |
Emedgene Automated Interpretation Software Integrated Into Illumina TruSight Software Suite |
| Dec 9, 2020 |
GenomeWeb |
Illumina, Harvard Pilgrim Health Care Ink Risk-Sharing Deal for Whole-Genome Sequencing |
| Dec 4, 2020 |
ClinicalOMICs |
Weill Cornell, NY-Presbyterian, Illumina Launch Large-Scale Clinical Sequencing Project |
| Dec 3, 2020 |
Genetic Engineering and Biotechnology News |
Large, Clinical, Sequencing Initiative Hopes to Uncover Genetic Disease Risk |
| Dec 3, 2020 |
WCBS News Radio 880 (New York) |
Wanted: Volunteers to donate DNA for advancement of personal health care |
| Dec 3, 2020 |
Becker's Hospital Review |
NewYork-Presbyterian, Weill Cornell team up on genomic technologies initiative |
| Dec 2, 2020 |
GenomeWeb |
China NMPA Approves Illumina NextSeq 550Dx Sequencer for Genetic Testing and Diagnosis |
| Dec 1, 2020 |
GenomeWeb |
UnitedHealthcare to Cover NIPT for Average-Risk Pregnancies |
| Dec 1, 2020 |
GenomeWeb |
Illumina, PierianDx Expand Partnership on Cancer Panel Test Reporting |
| Nov 20, 2020 |
GenomeWeb |
Illumina, IDbyDNA Flesh Out Sequencing-Based Respiratory Tests |
| Nov 13, 2020 |
Fierce Biotech |
Microsoft, Illumina, Twist ally to make big data small by weaving it into DNA archives |
| Nov 13, 2020 |
Investor's Business Daily |
Wild Ride For Illumina Stock Shows Promise, Challenge Of Multi-Cancer Blood Tests |
| Nov 12, 2020 |
GenomeWeb |
DNA Data Storage Alliance to Work on Interoperability, Industry Roadmap |
| Nov 12, 2020 |
SeekingAlpha |
Twist Bioscience and Illumina part of alliance to advance DNA data storage |
| Nov 12, 2020 |
GeekWire |
Microsoft helps found an industry alliance to advance DNA data storage systems |
| Nov 12, 2020 |
Genetic Engineering & Biotech News |
Illumina, Microsoft, Twist Lead New DNA Data Storage Alliance |
| Oct 30, 2020 |
BioWorld |
Illumina beats expectations in Q3, aided by sequencing consumables |
| Oct 30, 2020 |
The Motley Fool |
Why Illumina’s Q3 Results Were Better Than They Might Seem |
| Oct 28, 2020 |
Forbes |
How Human Genome Sequencing Went From $1 Billion A Pop To Under $1,000 |
| Oct 27, 2020 |
BioIT World |
Illumina Launches DRAGEN V3.7, Talks ML, Truth Challenges, All of Us |
| Oct 16, 2020 |
NPR |
A Boy’s Mysterious Illness Leads His Family On A Diagnostic Odyssey |
| Oct 15, 2020 |
Bloomberg |
Illumina and IDbyDNA Launch DNA Test That May Find Next Epidemic |
| Oct 13, 2020 |
Washington Post |
Scientists have a powerful new tool for controlling the coronavirus: Its own genetic code |
| Oct 12, 2020 |
Today News Africa |
$100 million pathogen genomics initiative launched in Africa |
| Sep 21, 2020 |
New York Post |
Biotech firm Illumina buying Jeff Bezos-backed startup Grail for $8 billion |
| Sep 21, 2020 |
FierceBiotech |
Illumina to pay $8B to reacquire cancer blood test maker Grail, with all eyes on 2021 |
| Sep 21, 2020 |
The Street |
Illumina Scoops Up Bezos-Backed Cancer-Detection Company Grail |
| Sep 21, 2020 |
Reuters |
Illumina to buy Jeff Bezos-backed cancer testing firm Grail in $8 billion deal |
| Sep 21, 2020 |
ClinicalOMICs |
Illumina to acquire GRAIL for $8 Billion |
| Sep 21, 2020 |
Investor's Business Daily |
Illumina Announces $8 Billion Acquisition Of Former Cancer-Testing Spinoff Grail |
| Sep 21, 2020 |
San Diego Union-Tribune |
Illumina to reunite with Grail for $8B in bold bid to detect cancer earlier |
| Sep 21, 2020 |
Forbes |
Biotech Firm Illumina Fell 15% In 5 Days – Should You Sell? |
| Sep 21, 2020 |
GenomeWeb |
Grail Deal Will Enable Illumina to Expand From Tech Innovator to Diagnostic Provider |
| Sep 21, 2020 |
Business Week |
Illumina’s $8bn holy GRAIL as it launches new era of cancer detection |
| Sep 21, 2020 |
TechCrunch |
Illumina buying cancer-screening spinout Grail in blockbuster $8B biotech deal |
| Sep 21, 2020 |
San Diego Times |
San Diego’s Illumina to Pay $7.1 Billion for Developer of Cancer Blood Test |
| Sep 15, 2020 |
The Age |
State-based genomic screening labs to be united in $3.3m project |
| Sep 8, 2020 |
Weekly Technology Times |
Genomic Medicine Applications Have Potential To Improve Health Care |
| Sep 7, 2020 |
Disrupt Africa |
Nigerian startup 54gene partners with US firm Illumina to launch Lagos genomics facility |
| Sep 3, 2020 |
Africa Business Magazine |
Illumina collaborates with 54gene in the creation of a world-class genomics facility in Nigeria |
| Aug 12, 2020 |
The Hindu |
CSIR moots ‘mega labs’ to boost COVID-19 testing |
| Aug 2, 2020 |
Financial Times |
Pandemic provokes new wave of funding for healthcare start-ups |
| Jul 7, 2020 |
GenomeWeb |
Illumina Looking to Streamline Genomic Interpretation With Two Informatics Acquisitions |
| Jun 27, 2020 |
The Age |
COVID-19 spotlight prompts calls for genomics roadmap |
| Apr 14, 2020 |
The Naked Scientists |
The Coronavirus Mutation Situation |
| Apr 7, 2020 |
Spiegel |
Pilotstudie zu neuem Corona-Testverfahren nahe München gestartet |
| Mar 26, 2020 |
National Geographic |
How coronavirus mutations can track its spread—and disprove conspiracies |
| Mar 18, 2020 |
Fierce BioTech |
Illumina taps IDbyDNA for infectious disease sequencing co-marketing initiative |
| Feb 7, 2020 |
CNBC |
Illumina CMO on working with China on coronavirus cure |
| Feb 7, 2020 |
The Smithsonian |
How Simple Blood Tests Could Revolutionize Cancer Treatment |
| Jan 13, 2020 |
CNBC |
ILMN CEO at J.P. Morgan Healthcare Conference |
| Jan 3, 2020 |
The Wall Street Journal |
Illumina, Pacific Biosciences of California End Plans to Combine |
| Dec 3, 2019 |
Yahoo! Finance |
ArcherDX Announces Partnership with Illumina to Develop In-Vitro Diagnostic Tests |
| Nov 11, 2019 |
ClinicalOMICS |
Lexent, Illumina Enter Partnership for Cancer Monitoring Liquid Biopsy Kits |
| May 26, 2022 |
The Straits Times |
Project SG100K: DNA of 100,000 Singaporeans to be mapped to identify new ways to prevent diseases |